Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2016

Mar 23, 2016

31580_dirs_2016-03-23_caaee504-fd35-47e4-931b-44db0d450589.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-11-16

Reporting Person: Cantley Lewis Clayton Jr. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-16 Common stock S 1362 $59.59 Disposed 141640 Direct
2015-11-16 Common stock S 1360 $59.58 Disposed 141642 Indirect
2015-11-17 Common stock S 3490 $59.99 Disposed 138150 Direct
2015-11-17 Common stock S 3492 $59.98 Disposed 138150 Indirect

Footnotes

F1: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.21 to $61.78. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This form 4 is amended to include the sale of 149 and 147 shares of the Company's common stock by the reporting person and the reporting person's spouse, respectively, on November 16, 2015. The sale of these shares was also not reflected in the securities beneficially owned by the reporting person and the reporting person's spouse on the three subsequent forms 4 filed by the reporting person.

F4: Shares held by Vicki Lee Sato, who is the reporting person's spouse.

F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.24 to $61.52. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.23 to $61.76. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.